Literature DB >> 15583654

Recombinant protein therapeutics--success rates, market trends and values to 2010.

Alex K Pavlou1, Janice M Reichert.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15583654     DOI: 10.1038/nbt1204-1513

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  39 in total

1.  Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins.

Authors:  Pietro Sormanni; Francesco A Aprile; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

2.  An all-aqueous route to polymer brush-modified membranes with remarkable permeabilites and protein capture rates.

Authors:  Nishotha Anuraj; Somnath Bhattacharjee; James H Geiger; Gregory L Baker; Merlin L Bruening
Journal:  J Memb Sci       Date:  2012-02-01       Impact factor: 8.742

3.  Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis.

Authors:  Jens Niklas; Eva Schräder; Volker Sandig; Thomas Noll; Elmar Heinzle
Journal:  Bioprocess Biosyst Eng       Date:  2010-12-25       Impact factor: 3.210

4.  A rapid and universal tandem-purification strategy for recombinant proteins.

Authors:  Andrew J McCluskey; Gregory M K Poon; Jean Gariépy
Journal:  Protein Sci       Date:  2007-10-26       Impact factor: 6.725

5.  European Union regulatory draft guidance on biogenerics containing recombinant human erythropoietin.

Authors:  Vladimir Trkulja
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

6.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

Review 7.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

Review 8.  Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

Authors:  C Andrew Boswell; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2007-06-08       Impact factor: 2.408

9.  Engineered Interactions with Mesoporous Silica Facilitate Intracellular Delivery of Proteins and Gene Editing.

Authors:  Bin Liu; Wardah Ejaz; Shuai Gong; Myrat Kurbanov; Mine Canakci; Francesca Anson; S Thayumanavan
Journal:  Nano Lett       Date:  2020-04-24       Impact factor: 11.189

10.  Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.

Authors:  Thomas D Dziubla; Vladimir V Shuvaev; Nan Kang Hong; Brian J Hawkins; Muniswamy Madesh; Hajime Takano; Eric Simone; Marian T Nakada; Aron Fisher; Steven M Albelda; Vladimir R Muzykantov
Journal:  Biomaterials       Date:  2007-10-24       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.